Peter Meijer sold Zoetis Inc (NYSE: ZTS)
Peter Meijer (R-MI), a U.S. Representative, has disclosed 1 trade in Zoetis Inc (ZTS) since 2021, a single sale.
The trade highlighted here is a sale: Peter Meijer sold Unknown of Zoetis Inc (NYSE: ZTS) on February 16, 2021. Since that trade, ZTS is down -51.85% against the S&P 500 up +103.09%, an outperformance of -154.94%.
Data updated
Peter Meijer's ZTS trades vs the price
ZTS is down -51.85% since Peter Meijer sold on February 16, 2021, versus +103.09% for the S&P 500.
Performance since this trade
All Peter Meijer ZTS trades
Peter Meijer & ZTS trading FAQ
Is it legal for Peter Meijer to trade Zoetis Inc (ZTS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Zoetis Inc (ZTS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Peter Meijer sell ZTS?
Peter Meijer disclosed a sale of Unknown of Zoetis Inc (ZTS) on February 16, 2021, according to public STOCK Act filings.
How has ZTS performed since Peter Meijer's trade?
Since Peter Meijer sold ZTS on February 16, 2021, the stock is down -51.85%, versus +103.09% for the S&P 500 over the same period, an outperformance of -154.94%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ZTS trades?
Quantellect tracks every disclosed congressional trade in Zoetis Inc (ZTS) on the Zoetis Inc congressional trading page, which aggregates filings across all members of Congress.
Peter Meijer's ZTS tradesAll congressional filings for Zoetis IncPeter Meijer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.